Cancer survivorship: an integral part of Europe's research agenda

Pernilla Lagergren^{1

2}, Anna Schandl^{1

3}, Neil K Aaronson⁴, Hans-Olov Adami^{5

6}, Francesco de Lorenzo^{7

8}, Louis Denis⁹, Sara Faithfull¹⁰, Lifang Liu¹¹, Franḉoise Meunier¹¹, Cornelia Ulrich^{12

13}; European Academy of Cancer Sciences

Affiliations

¹ Surgical Care Science, Department of Molecular medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
² Department of Surgery and Cancer, Imperial College London, UK.
³ Department of Quality and Patient Safety, Karolinska University Hospital, Stockholm, Sweden.
⁴ Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁵ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁶ Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Norway.
⁷ European Cancer Patient Coalition, Brussels, Belgium.
⁸ Italian Federation of Cancer Patients Organisations, Rome, Italy.
⁹ Oncology Centre Antwerp, Belgium.
¹⁰ Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
¹¹ Fédération of European Academies of Medicine, Brussels, Belgium.
¹² Huntsman Cancer Institute, Salt Lake City, UT, USA.
¹³ Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.

PMID: 30552794
PMCID: PMC6396379
DOI: 10.1002/1878-0261.12428

Review

Cancer survivorship: an integral part of Europe's research agenda

Pernilla Lagergren et al. Mol Oncol. 2019 Mar.

. 2019 Mar;13(3):624-635.

doi: 10.1002/1878-0261.12428. Epub 2019 Jan 8.

Authors

Affiliations

¹ Surgical Care Science, Department of Molecular medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
² Department of Surgery and Cancer, Imperial College London, UK.
³ Department of Quality and Patient Safety, Karolinska University Hospital, Stockholm, Sweden.
⁴ Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁵ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁶ Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Norway.
⁷ European Cancer Patient Coalition, Brussels, Belgium.
⁸ Italian Federation of Cancer Patients Organisations, Rome, Italy.
⁹ Oncology Centre Antwerp, Belgium.
¹⁰ Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
¹¹ Fédération of European Academies of Medicine, Brussels, Belgium.
¹² Huntsman Cancer Institute, Salt Lake City, UT, USA.
¹³ Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.

PMID: 30552794
PMCID: PMC6396379
DOI: 10.1002/1878-0261.12428

Abstract

Cancer survivorship has traditionally received little prioritisation and attention. For a long time, the treatment of cancer has been the main focus of healthcare providers' efforts. It is time to increase the amount of attention given to patients' long-term well-being and their ability to return to a productive and good life. This article describes the current state of knowledge and identifies research areas in need of development to enable interventions for improved survivorship for all cancer patients in Europe. The article is summed up with 11 points in need of further focus.

Keywords: cancer research; comprehensive cancer centres; long-term effects; research programmes; survivors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

1. Aaronson NK (1988) Quality of life: what is it? How should it be measured? Oncology (Williston Park) 2, 69–76, 64. - PubMed
1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ‐C30: a quality‐of‐life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85, 365–376. - PubMed
1. Aaronson NK, Mattioli V, Minton O, Weis J, Johansen C, Dalton SO, Verdonck‐de Leeuw IM, Stein KD, Alfano CM, Mehnert A et al (2014) Beyond treatment ‐ psychosocial and behavioural issues in cancer survivorship research and practice. EJC Suppl 12, 54–64. - PMC - PubMed
1. Albreht T, Borrás Andrés JM, Dalmas M, de Lorenzo F, Ferrari C, Honing C, Huovinen R, Kaasa S, Kiasuwa R, Knudsen AK et al (2017) Survivorship and Rehabilitation: Policy Recommendations for Quality Improvement in Cancer Survivorship and Rehabilitation in EU Member States. European Guide on Quality Improvement in Comprehensive Cancer Control. Scientific Institute of Public Health, National Institute of Public Health, Brussels.
1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, Bonaventure A, Valkov M, Johnson CJ, Esteve J et al (2018) Global surveillance of trends in cancer survival 2000‐14 (CONCORD‐3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population‐based registries in 71 countries. Lancet, 391, 1023–1075. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cancer survivorship: an integral part of Europe's research agenda

Affiliations

Cancer survivorship: an integral part of Europe's research agenda

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources